Previously submitted to: JMIR Cancer (no longer under consideration since Dec 13, 2023)
Date Submitted: Jan 21, 2023
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Development of the Cancer Exercise app: Individualized exercise programs for people living with and beyond cancer and caregivers.
ABSTRACT
Background:
Exercise is important for the health of people living with and beyond cancer. Yet most cancer survivors do not receive advice or referral to exercise oncology programs. A smartphone delivered exercise oncology specific app could minimize many of the barriers to exercise that these individuals face.
Objective:
To develop an exercise oncology application that delivers an individualized exercise program for each user to minimize many of the barriers faced by clinicians, patients and people in underserved areas.
Methods:
The app was developed based on previous research. The individualized exercise prescription is based on the user’s daily level of fatigue, and if the user is on treatment, type and duration of treatment, and current fitness level.
Results:
Developed an easy to navigate, read and use app with reminders to exercise and positive feedback for reaching one’s goals.
Conclusions:
Cancer Exercise is a unique app that provides individualized exercise programs for cancer survivors and caregivers. Additional research is needed to see how the app may benefit people living in rural and underserved communities.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.